Jenrry Mejia left Mets camp and went to New York to be examined for a hyperactive thyroid, but the 23-year-old right-hander has been cleared to return to spring training.
It all started when doctors red-flagged something during Mejia’s annual physical exam, but according to manager Terry Collins he’ll have “no limitations.”
Officially the Mets haven’t actually said what the issue was and MLB.com continues to call it simply “a medical issue unrelated to his pitching arm.” However, several reporters had the thyroid-related details and Mejia himself told Adam Rubin of ESPN New York that he’s been advised to stay away from seafood to keep things in check.
The Angels signed Japanese superstar Shohei Ohtani for a $2.3 million signing bonus last weekend. They may have damaged goods on their hands. Jeff Passan of Yahoo Sports reports that Ohtani underwent a physical that revealed a first-degree sprain of his ulnar collateral ligament. As a result, he got a platelet-rich plasma injection on October 20. This was made known to teams after Ohtani entered MLB’s posting system, so it wasn’t like the Angels went into this blind.
Ohtani’s report said, “Although partial damage of UCL in deep layer of his right UCL exists, he is able to continue full baseball participation with sufficient elbow care program.” It also said Ohtani “will most likely be available to start his throwing program approximately a month from the PRP.”
Passan notes that the report also mentioned that a “small free body” floats in Ohtani’s elbow near his UCL.
Ohtani isn’t without other injuries. He battled hamstring and ankle issues throughout 2017 and underwent right ankle surgery back in October. Thankfully for the Angels, this diagnosis is about as good as it could be considering the circumstances. However, if Ohtani does exacerbate his UCL issue, he may ultimately need Tommy John surgery at some point, which would take him out of action for at least a year.